| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84443 |
Thyroid stimulating hormone (TSH) |
3,690 |
3,619 |
$65K |
| 80061 |
Lipid panel |
4,367 |
4,273 |
$61K |
| 80053 |
Comprehensive metabolic panel |
4,840 |
4,702 |
$54K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,288 |
5,070 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
759 |
702 |
$33K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,393 |
2,347 |
$25K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
704 |
648 |
$17K |
| 81000 |
|
4,936 |
4,783 |
$16K |
| 82274 |
|
635 |
618 |
$11K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
261 |
254 |
$8K |
| 84436 |
|
988 |
965 |
$7K |
| 86328 |
|
379 |
366 |
$7K |
| 86701 |
|
649 |
637 |
$6K |
| 84153 |
|
299 |
293 |
$6K |
| 82043 |
|
856 |
836 |
$5K |
| 85027 |
|
715 |
671 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
91 |
82 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
353 |
174 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
573 |
511 |
$3K |
| 87088 |
|
303 |
294 |
$3K |
| 84479 |
|
291 |
277 |
$2K |
| 84439 |
|
152 |
152 |
$1K |
| 87490 |
|
64 |
64 |
$1K |
| 86738 |
|
72 |
72 |
$1K |
| 81001 |
|
326 |
320 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
81 |
75 |
$660.29 |
| 82607 |
|
40 |
40 |
$657.20 |
| 86803 |
|
34 |
34 |
$528.70 |
| 82270 |
|
43 |
40 |
$297.36 |
| 85730 |
|
29 |
26 |
$182.99 |
| 85610 |
|
32 |
28 |
$132.81 |
| 86592 |
|
29 |
27 |
$130.47 |
| 82570 |
|
14 |
14 |
$78.96 |
| 82950 |
|
13 |
13 |
$67.34 |
| 82947 |
|
12 |
12 |
$47.08 |
| 85652 |
|
13 |
13 |
$38.10 |